Literature DB >> 21359521

Survey on the prevalence of GERD and FD based on the Montreal definition and the Rome III criteria among patients presenting with epigastric symptoms in Japan.

Shuichi Ohara1, Tatsuyuki Kawano, Motoyasu Kusano, Teruo Kouzu.   

Abstract

BACKGROUND: The present survey aimed to clarify the prevalence of gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) in patients presenting with epigastric symptoms in Japan based on the Montreal definition and the Rome III criteria, respectively, and to determine the degree of overlap between the two disease entities and the validity of using these Western-developed diagnostic criteria in Japan.
METHODS: Patients presenting with epigastric symptoms for whom the first upper gastrointestinal endoscopy was scheduled from April through August 2007 at 55 institutions were asked to complete a questionnaire to ascertain the type, frequency, and severity of epigastric symptoms. The prevalence of esophageal mucosal damage was also determined from endoscopic findings.
RESULTS: A total of 1,076 patients were included in the analysis population. There was a high degree of coincidence for all symptoms, with the mean number of symptoms per patient of 2.8. With strict application of the Montreal and Rome III definitions, symptomatic GERD accounted for 15.6% (168 patients), whereas FD accounted for 10.3% (111 patients), and the overlap between GERD and FD symptoms was less than 10%. However, when frequency and severity alone were considered in more broadly defined criteria, the overlap between GERD and FD symptoms was 30-40%.
CONCLUSION: A highly specific disease classification is possible when the Montreal definition and the Rome III criteria are strictly applied. On the other hand, the present survey highlighted a problem with the criteria whereby a definitive diagnosis could not be made in a substantial number of patients. This problem will require further research.

Entities:  

Mesh:

Year:  2011        PMID: 21359521     DOI: 10.1007/s00535-011-0382-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  10 in total

Review 1.  The functional gastrointestinal disorders and the Rome III process.

Authors:  Douglas A Drossman
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

2.  Gastrointestinal symptoms and subjects cluster into distinct upper and lower groupings in the community: a four nations study.

Authors:  N J Talley; G Holtmann; L Agréus; M Jones
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

3.  The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus.

Authors:  Nimish Vakil; Sander V van Zanten; Peter Kahrilas; John Dent; Roger Jones
Journal:  Am J Gastroenterol       Date:  2006-08       Impact factor: 10.864

4.  Overlap of gastrointestinal symptom complexes in a US community.

Authors:  G R Locke; A R Zinsmeister; S L Fett; L J Melton; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2005-02       Impact factor: 3.598

Review 5.  Functional gastroduodenal disorders.

Authors:  Jan Tack; Nicholas J Talley; Michael Camilleri; Gerald Holtmann; Pinjin Hu; Juan-R Malagelada; Vincenzo Stanghellini
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

6.  Differences in recognition of heartburn symptoms between Japanese patients with gastroesophageal reflux, physicians, nurses, and healthy lay subjects.

Authors:  Noriaki Manabe; Ken Haruma; Jiro Hata; Tomoari Kamada; Hiroaki Kusunoki
Journal:  Scand J Gastroenterol       Date:  2008       Impact factor: 2.423

7.  Nationwide epidemiological study on gastroesophageal reflux disease and sleep disorders in the Japanese population.

Authors:  Motoyasu Kusano; Teruo Kouzu; Tatsuyuki Kawano; Shuichi Ohara
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

8.  Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett's esophagus.

Authors:  Helmut Neumann; Klaus Monkemuller; Arne Kandulski; Peter Malfertheiner
Journal:  Dig Dis       Date:  2008-05-07       Impact factor: 2.404

9.  Functional dyspepsia: not all roads seem to lead to rome.

Authors:  Lieke A S van Kerkhoven; Robert J F Laheij; Villy Meineche-Schmidt; Sander J Veldhuyzen-van Zanten; Niek J de Wit; Jan B M J Jansen
Journal:  J Clin Gastroenterol       Date:  2009-02       Impact factor: 3.062

10.  The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.

Authors:  Anjiang Wang; XianHua Liao; LiShou Xiong; Sui Peng; YingLian Xiao; SiChun Liu; PinJin Hu; MinHu Chen
Journal:  BMC Gastroenterol       Date:  2008-09-23       Impact factor: 3.067

  10 in total
  10 in total

1.  Prevalence of uninvestigated dyspepsia and gastroesophageal reflux disease in Korea: a population-based study using the Rome III criteria.

Authors:  Byung-Hoon Min; Kyu Chan Huh; Hye-Kyung Jung; Young Hoon Yoon; Kee Don Choi; Kyung Ho Song; Bora Keum; Jung Won Kim
Journal:  Dig Dis Sci       Date:  2014-06-13       Impact factor: 3.199

2.  Prevalence of Gastroesophageal Reflux Disease and Proton Pump Inhibitor-Refractory Symptoms.

Authors:  Sean D Delshad; Christopher V Almario; William D Chey; Brennan M R Spiegel
Journal:  Gastroenterology       Date:  2019-12-19       Impact factor: 22.682

3.  Overlap in patients with dyspepsia/functional dyspepsia.

Authors:  Yasuhiro Fujiwara; Tetsuo Arakawa
Journal:  J Neurogastroenterol Motil       Date:  2014-09-26       Impact factor: 4.924

4.  Development and validation of a simple and multifaceted instrument, GERD-TEST, for the clinical evaluation of gastroesophageal reflux and dyspeptic symptoms.

Authors:  Koji Nakada; Nobuyuki Matsuhashi; Katsuhiko Iwakiri; Atsushi Oshio; Takashi Joh; Kazuhide Higuchi; Ken Haruma
Journal:  World J Gastroenterol       Date:  2017-07-28       Impact factor: 5.742

5.  Clinical course of biliary-type sphincter of Oddi dysfunction: endoscopic sphincterotomy and functional dyspepsia as affecting factors.

Authors:  Hiroyuki Miyatani; Hirosato Mashima; Masanari Sekine; Satohiro Matsumoto
Journal:  Ther Adv Gastrointest Endosc       Date:  2019-08-12

6.  Efficacy of massage therapy for postprandial distress syndrome: A protocol for systematic review and meta-analysis.

Authors:  Ke-Lin Zhou; Shuo Dong; Qian Shen; Kang Wang; Pei-Dong Wei; Xiao Bai; Ming-Heng Cai; Sheng Guo; Yang Liu
Journal:  Medicine (Baltimore)       Date:  2020-11-25       Impact factor: 1.889

7.  Evaluation of QOL in Patients with Dyspeptic Symptoms Who Meet or Do Not Meet Rome IV Criteria.

Authors:  Masatoshi Mieno; Toshihiko Tomita; Sota Aono; Katsuyuki Tozawa; Keisuke Nakai; Takuya Okugawa; Masashi Fukushima; Tadayuki Oshima; Hirokazu Fukui; Hiroto Miwa
Journal:  J Clin Med       Date:  2021-12-22       Impact factor: 4.241

8.  Hesperidin promotes gastric motility in rats with functional dyspepsia by regulating Drp1-mediated ICC mitophagy.

Authors:  Qingling Jia; Li Li; Xiangxiang Wang; Yujiao Wang; Kailin Jiang; Keming Yang; Jun Cong; Gan Cai; Jianghong Ling
Journal:  Front Pharmacol       Date:  2022-08-12       Impact factor: 5.988

9.  Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome.

Authors:  Shadi S Yarandi; Jennifer Christie
Journal:  Gastroenterol Res Pract       Date:  2013-05-16       Impact factor: 2.260

10.  Epidemiology and risk factors of uninvestigated dyspepsia, irritable bowel syndrome, and gastroesophageal reflux disease among students of Damascus University, Syria.

Authors:  Tareq Al Saadi; Amr Idris; Tarek Turk; Mahmoud Alkhatib
Journal:  J Epidemiol Glob Health       Date:  2016-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.